| Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant M Fan, PS Yan, C Hartman-Frey, L Chen, H Paik, SL Oyer, JD Salisbury, ... Cancer research 66 (24), 11954-11966, 2006 | 294 | 2006 |
| Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells PH Abbosh, JS Montgomery, JA Starkey, M Novotny, EG Zuhowski, ... Cancer research 66 (11), 5582-5591, 2006 | 142 | 2006 |
| Role of dopamine receptors in the anticancer activity of ONC201 CLB Kline, MD Ralff, AR Lulla, JM Wagner, PH Abbosh, DT Dicker, ... Neoplasia 20 (1), 80-91, 2018 | 125 | 2018 |
| Mutations in renal cell carcinoma C D'Avella, P Abbosh, SK Pal, DM Geynisman Urologic Oncology: Seminars and Original Investigations 38 (10), 763-773, 2020 | 102 | 2020 |
| Multiple signaling pathways converge on β-catenin in thyroid cancer PH Abbosh, KP Nephew Thyroid 15 (6), 551-561, 2005 | 85 | 2005 |
| Germ cell origin of testicular carcinoid tumors PH Abbosh, S Zhang, GT MacLennan, R Montironi, A Lopez-Beltran, ... Clinical Cancer Research 14 (5), 1393-1396, 2008 | 55 | 2008 |
| Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder PH Abbosh, M Wang, JN Eble, A Lopez-Beltran, GT MacLennan, ... Modern Pathology 21 (3), 355-362, 2008 | 48 | 2008 |
| Targeting signaling transduction pathways in bladder cancer PH Abbosh, DJ McConkey, ER Plimack Current oncology reports 17, 1-10, 2015 | 40 | 2015 |
| P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting P Gokare, NK Finnberg, PH Abbosh, J Dai, ME Murphy, WS El-Deiry Scientific Reports 7 (1), 9711, 2017 | 30 | 2017 |
| A conditionally replicative, Wnt/β-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer PH Abbosh, X Li, L Li, TA Gardner, C Kao, KP Nephew Cancer gene therapy 14 (4), 399-408, 2007 | 25 | 2007 |
| Camera-port site metastasis of a renal-cell carcinoma after robot-assisted partial nephrectomy JB Song, YS Tanagho, EH Kim, PH Abbosh, G Vemana, RS Figenshau Journal of endourology 27 (6), 732-739, 2013 | 21 | 2013 |
| Laparascopic capsulotomy to treat autoinflation of inflatable penile prostheses PH Abbosh, MR Thom, A Bullock The Journal of Sexual Medicine 9 (4), 1212-1215, 2012 | 15 | 2012 |
| Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma AF Correa, KJ Ruth, T Al-Saleem, J Pei, E Dulaimi, D Kister, M Collins, ... Cancer biology & therapy 21 (5), 424-431, 2020 | 10 | 2020 |
| The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution DD Nguyen, WF Hooper, W Liu, TR Chu, H Geiger, JM Shelton, M Shah, ... Nature 635 (8037), 219-228, 2024 | 6 | 2024 |
| Novel biomarkers in chromophobe renal cell carcinoma: distinguishing it from its mimics J Drevik, P Abbosh European urology 78 (1), 75-76, 2020 | 6 | 2020 |
| Hybrid renal tumors in Birt-Hogg-Dubé syndrome. PH Abbosh, RL Grubb 3rd, D Cao, PA Humphrey The Journal of urology 186 (6), 2413-2414, 2011 | 6 | 2011 |
| Thermoablation of renal masses: the urologist's perspective PH Abbosh, SB Bhayani Seminars in interventional radiology 28 (04), 361-366, 2011 | 5 | 2011 |
| Measuring the efficacy and value of urothelial cancer urinary biomarkers PH Abbosh, ER Plimack Annals of Internal Medicine 163 (12), 954-955, 2015 | 4 | 2015 |
| MP56-10 CHARACTERIZATION AND FUNCTIONAL ANALYSIS OF MICROBIOME IN BLADDER CANCER L Bukavina, A Calaway, I Isali, M Prunty, M Sindhani, M Ghannoum, ... Journal of Urology 207 (Supplement 5), e975, 2022 | 3 | 2022 |
| Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis I Isali, P McClellan, A Calaway, M Prunty, P Abbosh, K Mishra, L Ponsky, ... Urologic Oncology: Seminars and Original Investigations 40 (5), 197. e11-197 …, 2022 | 3 | 2022 |
